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Abstract
From studies in the mouse and from the 
clinical and molecular analysis o f patients 
with type 1 Waardenburg syndrom e, par« 
ticular members of the PAX gene fam ily  
are suspected factors in the aetiology o f  
human neural tube defects (NTD). To 
investigate the role of PAX1, PAX3, PAX7, 
and PAX9, allelic association studies were 
performed in 79 sporadic and 38 fam ilial 
NTD patients from the Dutch population. 
Sequence variation was studied by SSC  
analysis of the paired domain regions o f  
the PAX1, PAX7, and PAX9 genes and o f  
the complete PAX3 gene. In one patient 
with spina bifida, a mutation in the PAX1 
gene was detected changing the conserved  
amino acid Gin to His at position 42 in the 
paired domain of the protein. The m uta­
tion was inherited through the m aternal 
line from the unaffected grandmother and  
was not detected in 300 controls. In the 
PAX3 gene, variation was detected at sev ­
eral sites including a Thr/Lys am ino acid  
substitution in exon 6. All alleles were 
present among patients and controls in  
about the same frequencies. However, an 
increased frequency of the rare allele o f  a 
silent polymorphism in exon 2 was found  
in NTD patients, but no significant associ­
ation was observed (p=0.06). No sequence  
variation was observed in the paired  
domain of the PAX7 and PAX9 genes.
Our findings so far do not support a major 
role of the PAX genes exam ined in the  
aetiology of NTD. However, the detection  
of a mutation in PAX1 suggests that, in  
principle, this gene can act as a risk factor 
for human NTD.
(JMed Genet 1996;33:655-660)
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Neural tube defects (NTD) constitute a major 
group of congenital malformations with an 
incidence of approximately 1/1000 pregnan­
cies, It is generally accepted that they represent 
multifactorial traits with genetic and environ­
mental factors contributing to the aetiology. 
Information about the identity of the genetic 
factors involved is scarce. Induction of N T D
NTD by folic acid2 suggest that genes for drug 
receptors or metabolic enzymes may play a
role. Pedigree analysis and linkage data suggest 
that the human X chromosome contains one or 
more contributing genetic factors.3 More 
specifically, several members of the PAX gene 
family, encoding a class of related embryonic 
transcription factors,4 have been proposed as 
candidate genes for NTD,5 6 At present nine 
members have been identified and studies in 
the mouse have shown that they are all 
expressed in the developing brain, the neural 
tube, or the paraxial mesoderm.
Mutations in the gene for Pax-1 are respon­
sible for the phenotype of the mouse strain 
undulated with various vertebral anomalies.7 8 
Interestingly, litters resulting from a cross 
between undulated (un) and Patch (Ph) mice 
have a high incidence of lumbar spina bifida 
occulta5 indicating that Pax-1 can be involved 
in specific forms of NTD.
From die association between spina bifida 
and Waardenburg syndrome type 1 (WSl),°~lfi 
the PAX3 gene can be regarded as a risk factor 
for human NTD. Mutations in this gene have 
been detected in various patients with both 
spina bifida and WS1.17' 19 Moreover, mutations 
in the murine homologue of this gene cause the 
Splotch phenotype. Homozygous Splotch mice 
exhibit severe NTD6 whereas heterozygous 
PaX'3 mutations seem to increase the inci­
dence of NTD in other predisposed strains.20 
Linkage analysis has not provided genetic 
evidence for a major role of PAX3 in human
N T D .21
The above findings prompted us to investi­
gate further the role of PAX1 and PAX3, and 
their paralogues PAX9 and PAX7, respectively, 
by searching for mutations and sequence vari­
ants in association with non-syndromic NTD*
M aterials and methods
ASCERTAINMENT OF PATIENTS
Patients with non-syndromic N T D  were se­
lected from the Dutch population in collabora­
tion with the Dutch patient organisation 
BOSK and from the records of our institute, 
Multiple case families were selected according 
to the criteria described previously.22 In short, 
there had to be two or more affected members 
in each family with a close degree of relation­
ship (^3 ). In this way 38 multiple case families 
were selected. One affected member of each of 
these families was included in the present 
study. The types of N TD  in this group were: 
spina bifida (36), encephalocele (1), and 
craniorachischisis (1). In addition, a group of
Figure 1 Schematic representation of parts of the different P A X  genes that were subjected to SSC  analysis, Arrowheads 
with connecting bars represent the amplification primers and amplified fragments. The filled region, the hatched region3 and 
the double hatched region represent the paired domain, the octapeptide sequence, and the homeodomain, respectively,
79 sporadic patients was also analysed, which 
included patients with spina bifida (75), with 
anencephaly (2), and with encephalocele (2). 
Unaffected and unrelated subjects were ran­
domly chosen from the Dutch population and 
used as a control group in the present study. 
Blood was sampled and DNA was extracted 
according to the procedure of Miller et a l 23.
SSC ANALYSIS
PCR amplification was performed to produce 
the appropriate DNA fragments (fig 1). Ampli­
fication was carried out in a total volume of 25 
jj1 containing 50 n g  of genomic DNA;, 0.45 
mmol/1 of each primer (table 1; Isogen 
Bioscience, The Netherlands);, 0.1 mmol/1 
dCTP, 0.4 mmol/1 dATP, 0.4 mmol/1 dGTP, 
0.4 mmol/1 dTTP, 0.1 l^1 [ct[32]P]dCTP 
(Amersham) in PCR buffer (50 mmol/1 KCl,
10 mmol/1 TRIS-HCL, pH 8.3, 1 mmol/1 DTE, 
0.001% gelatine, 1 , 5 - 6  mmol/1 MgCl2) with
0,5 U of Taq DNA polymerase (Boehringer, 
Mannheim). Samples were denatured at 92°C
for five minutes and then subjected to 35 cycles 
of amplification: 92°C for 50 seconds, 55°C for 
50 seconds, 72°C for one minute 30 seconds. 
Aliquots of the amplified DNA were mixed 
with 1 volume formamide dye buffer, dena­
tured at 95°C for five minutes, and placed on 
ice. Samples (4 ji) were loaded on a 5% 
non-denaturing polyacrylamide gel containing 
10% glycerol and on a similar gel without glyc­
erol, Electrophoresis was for 3-6 hours at 40 W 
and 4°C, The gels were dried and exposed 
overnight on Kodak X-omat S film.
SEQUENCING OF NORMAL AND VARIANT ALLELES
To determine the molecular nature of the 
shifted bands observed by SSC analysis, bands 
representing wild type and variant alleles were 
cut out of the gel. DNA was eluted from each 
of the gel slices in 50 jxl aquadest for one hour 
at 37°C and reamplified under the conditions 
described above, Subsequently, the amplified 
DNA fragments were purified by electrophore­
sis on a 1% agarose gel (one hour, 10 V/cm),
Table 1 Primers used for SSC analysis 18 28-31
i
S ize (bp) Forward primer Reverse primer
PAX3
I 138 5 '~C CTG GATATAATTTC C GAGCG-3’ 5’-CGCTGAGGCCCTCCCTTA-3’
2A 266 S’-GAAGACTGCGAAATTACGTGCTGC-S' 5’-ACAGGATCTTGGAGACGCAGCC-3'
2B 20 S 5 AAC C AC AT C C GC C AC AAG AT C G-3' 5 '-G AC C AC AGTCTGG G AG C C AG G AGG- 3 '
3 237 5'~CACCTGGCCCAGGGTACCGGGTAC~3' 5-CGGGGTAATAGCGACTGACTGTC-3'
4 252 S'-AGCCCTGCTTGTCTCAACCATGTG^' 5-TGC C CTCCAAGTCACCCAGCAAGT-3 '
5 304 S'-GACTTGGATCAATCTCAGTTTT-S1 5'-TAGGACACGGAGGTTTGG-3'
6 250 5' -TTC AT C AGTGAAAT C CTTAAATT-3' 5'-CGCCTGGAAGTTACTTTCTA-3'
7 320 5'-GAACT iTCTCTGCTGGCCTA-3' 5-TGGTTCTGGTATACAGCAAATC-3'
S 313 5h-GCTCTTTTTTTAGGTAATGGGA-3’ 5 '-TG A G rnA TC TC C C TTC C A G G -3'
PAX7
2A 188 S'-TCCATCCTCACCCTGCACCT-S' 5'-CGGGAGATGACACAGGGCCG-3'
2B 214 5'-GCGACCCCTGCCTAACCACA-3’ 5’-AAGCCAGCTGCCAGCCTCTGTG-3'
3 200 S'-CCCCATCCCATCTTTCCACTC-^ 5'-TGCCGGCTCAGCTGCCTTCTCA-3'
4 189 5 '-TTG CTCTTTTG  C CTTTGAA' ITT ‘CT- 3 ' 5'-GCCTCGCAGCCCAGGGAA-3'
PAX1
I 194 5-TCCGGCTCACTCTTGTCTGG-3' 5'-ATCTTGCTCACGCAGCCGTG-3'
2 201 . 5-ACGCCATCCGCTTGCGCATT-3' 5 AGTC CCGGATGTGCTTGACC - 3 ’
3 200 51-CCTGGCGCGCTACAACGAGA-3' 5-TGGAGCTCACCGAAGGCACA-3'
4 200 S'-CTGGCATC'ITTGCCTGGGA G-3r 5 AG GG GTACTG GTAG ATGTGG- 3 '
PAX9
1 200 5 '-ATTTTGCAGAGCC AGCCTTC-3 ' 5'-CGAGCCCGTCTCGTTGTATC-3'
2 188 5'-GGC CCAACTGGGCATC CGAC-3’ 5 -GGTCTCTCTGCTTGTAGGTC-31
3 202 5'-ATCTTGCCAGGAGCCATCGG-3l 5'-TGCCGATCTTGTTGCGCAGAAT-3'
4 200 S'-ATCTTCGCCTGGGAGATC CGG-3' 5 G GGTAC G AGTAG ATGTG GTTGT- 31
5 222 5’-ATTACGACTCATACAAGCAGCACC-3' 5-CCCTACCTTGGTCGGTGATGG-3'
P A X  genes and human N TD 657
allowed to migrate into ultra low gelling 
temperature agarose (Sigma), and sliced out of 
the gel. This material served as substrate for 
direct sequencing using a cycle sequence kit 
according to the protocol of the manufacturer 
(BRL). Sequences were determined in two 
directions with the forward and reverse ampli­
fication primers after 5' end labelling with 
[32] P. Whenever the resolution was too poor to 
cut the allelic bands out of the SSC gel 
separately, non-radio active PCR was per­
formed on genomic DNA. Amplification prod­
ucts were purified on an agarose gel and cloned 
into the Smal site of plasmid vector Bluescript 
SK+ (Stratagene). Dideoxy DNA sequencing 
was conducted on double stranded DNA from 
positive clones using the T7 sequencing kit 
(Pharmacia) with T7 and T3 primers. Se­
quences were obtained from at least three 
independent clones.
Results
SSC ANALYSIS OF THE PAXl AND PAX9 GENES
Double mutant mice with the genotype {un/ 
un;Ph/+} exhibit an occult form of spina 
bifida5 indicating that mutations in Pax-1 can 
influence the development of the vertebral 
arches. In order to assess the relevance of 
PAXl for human NTD> the paired domain 
region, which is the only part of the gene that 
has been cloned to date, was subjected to SSC 
analysis. DNA from 79 sporadic and 38 famil­
ial NTD patients from the Dutch population 
was screened for the presence of sequence vari­
ation (fig 1). This resulted in the detection of a 
shifted band in a single sporadic patient with 
spina bifida (fig 2A). Direct sequencing of the 
shifted fragment showed a nucleotide substitu­
tion (G—>C> fig 3A) leading to the exchange of 
glutamine at position 42 of the paired domain 
by histidine. This nucleotide substitution 
disrupts an A lu l restriction site in the gene. 
Therefore, the presence of the base change 
could be confirmed by A lu l  restriction diges­
tion of the PCR product leaving the DNA from 
this patient intact (fig 4). In the same way it 
was shown that the base change was absent
from 300 unaffected controls suggesting that 
this alteration is aetiologically related to the 
NTD of this person. Moreover the functional 
importance of the Gin residue at this position 
is corroborated by the fact that it has been con­
served between several human PAX genes as 
well as the murine Pax-1 gene (fig 5). Finally, 
the predicted structure of the m utant peptide 
showed the loss of a beta sheet conformation 
surrounding the displaced amino acid (fig 6). 
Together, these results argue for a contribution 
of the PAXl mutation to the development of 
spina bifida in one patient. However, the same 
mutation was also found in the unaffected 
mother and grandmother showing that this 
factor alone is not sufficient to induce a N TD  
during embryogenesis.
In addition, we have examined all patients 
for sequence variation in the paired domain of 
the PAX9 gene (fig 1), which is highly homolo­
gous to the PAXl gene. No band shifts were 
detected.
SSC ANALYSIS OF THE PAX3 AND PAX7 GENES
Although linkage studies have not provided any
i
indication for PAX3 being a major aetiological 
factor for familial N TD ,21 a less prominent role 
cannot be excluded in this way, in particular for 
sporadic cases. Therefore, a similar strategy 
was applied as performed for the PAXl gene, 
that is, using SSC analysis to search for muta­
tions or rare sequence variants primarily 
occurring among patients. The complete cod­
ing sequence of the PAX3 gene contained in 
exons 1 to 8, together with their flanking intron 
sequences, were analysed (fig 1), The most 
dramatic change in the banding patterns was 
observed for exon 5 in a familial patient. The 
detailed analysis of this case, which turned out 
to be a 5 bp deletion causing spina bifida and 
WS1, has been described elsewhere.19 Besides 
the normal band pattern, shifted bands were 
detected for exons 2, 6, and 7 (fig 2). The 
nature of the observed shifts was determined as 
described in Materials and mediods. One of 
the shifts observed for the exon 2 fragment (fig 
2B) and the shift observed for the exon 7 frag-
PAX1 PAX 3
P C C P C C P C C P C C P C C
Paired
domain
exon
B
* ^  # s i i —'/t . ‘ V, ; r f  (V>>: i .
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Figure 2 Allelic band pattern obtained through SSC  analysis of different fragments of the PA X l gene (A) and the PAX3 
gene (B-E) . The first lane shows the altered pattern (P) which was occasionally observed inpatients or controls or both, 
whereas the more common SSC  pattern (C) is shown in lanes 2 and 3. Arrowheads mark the observed shifted allelic bands.
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Tabic 2 Frequencies of the different SSC  shifts in the PAX3 gene m Dutch patients and 
controls
Patients Controls
SSC fragment No Frequency No Frequency
Exon 2 (5' intron polymorphism) 5 / 64 0.08 8 / 93 0,09
Exon 2 (silent polymorphism) 4 2 / 113 0.37 6 0 /2 2 9  0.26
Exon 6 (AA polymorphism) 3 / 61 0.05 6 /9 3  0.06
Exon 7 (3' intron polymorphism) ND - ND
ment (fig 2E) were shown to represent single 
nucleotide substitutions in the 51 and 3' 
flanking intronic sequences of exon 2 (T—>C, 
fig 3B) and 7 (G->A, fig 3E), respectively. 
Another shift of the same fragment of exon 2 
(fig 2C) turned out to be the result of a single 
nucleotide substitution (C-»T) at the third 
position of codon 43 representing a silent base 
change (GIy43Gly, fig 3C), which has previ­
ously been reported by Tassabehji et a i 24 In die 
3' half of exon 6, a C-^A change was identified 
(fig 2D) downstream of the homeo domain
A
B
C
c
t
51 -actgcgaaattacgtgctgctgttctttgctttt 
tattttcctccagtgacttttcccttgcttctct
Intron 1 Exon 2
ttttcaccttcccacagTGTCCACTCCCCTCGGC-3
p
A 
X 
1 
1
D
A
\
Exon 6
5'-TACCAGCCCACATCTATTCCACAAG 
TyrGlnProThrSeriieProGln
t
Lys
Intron 6 
gtaccgagg-31
E
Exon 7 Intron 7
I
P 
A 
X 
3
51 -CCTCTCACCTCAGgtcagtcccgtgtttctagac-3
Figure 3 Partial DNA and protein sequence of the paired domain exon of P A X  1 (A), as 
well as PAX3 exon 2 (B} C)} exon 6 (D)t and exon 7 (E), The nucleotide substitutions that 
are responsible for the SSC  shifts in fig  2 are shown. When the nucleotide substitution gives 
rise to an amino acid substitution in the deduced peptidet this is also shown.
Table 3  Frequency of the T  allele chromosome of the exon 
2 C/Tpolymorphism in Dutch patients and controls
Patients Controls
No Frequency No Frequency p value
T  allele 46/226 0.20 67/458 0.15 0.06
resulting in an amino acid substitution 
(Thr315Lys, fig 3D). According to the struc­
ture prediction analysis (not shown) this amino 
acid substitution does not seem to be influenc­
ing the protein structure, Genotyping of the 
control group showed that all the sequence 
variants were present both in patients and con­
trols with approximately equal frequencies in 
both groups (table 2) . Interestingly, the T  allele 
of the exon 2 silent polymorphism seemed to 
be present more often in patients than in con­
trols. However, a thorough analysis of the data 
(heterozygosity/homozygosity scoring, T  allele 
frequency determination) applying chi-square 
statistics* did not show a significant association 
between the T  allele and N TD  (p=0.06, odds 
ratio = 1.49, 95% confidence interval 0.96- 
2.30; table 3).
Finally, for PAX7, which closely resembles 
PAX3 in structure and expression, the same 
groups of patients and controls were screened 
for the presence of sequence variation in the 
paired domain (exons 2 to 4, fig 1), which is the 
only part of this gene cloned so far. No band 
shifts were detected in the SSC analysis.
D iscussion
PAX genes encode a class of highly conserved 
transcription factors with a characteristic DNA 
binding paired domain, which play important 
roles in embryonic development.4 To deter­
mine more accurately the extent to which 
genetic variation in the PAX1 and PAX3 genes, 
and their paralogues PAX9 and PAX7, might 
predispose to NTD we have performed SSC 
analysis of both familial and sporadic patients. 
Analysis of the paired domain of PAX1 showed 
a missense mutation in one sporadic NTD 
patient. The NTD was detected by amniocen­
tesis and biochemical analysis of amniotic 
fluid, indicated by the fact that the mother was 
a known carrier of a balanced translocation 
t(7;20)(q22;ql3.2). After pregnancy termina­
tion at 19 weeks of gestation, clinical examin­
ation showed an open lumbar spina bifida of 
about 1.5 cm in size. Uniparental disomy of 
chromosome 7 or 20 in the fetus was excluded 
by the analysis of genetic markers. Cytogenetic 
analysis showed the presence of the same 
balanced translocation in the fetus and the 
maternal grandmother. Apparently, the muta­
tion in the PAXl gene, which is located at 
2 0 p ll ,  cosegregates with the translocation 
chromosomes. Although there is no indication 
for a major pathological effect of the balanced 
translocation, an influence on the phenotype of 
the fetus cannot be excluded. In fact, under a 
multifactorial threshold model both genetic 
abnormalities, that is, the PAXl mutation and 
the translocation, may have contributed to die 
appearance of the NTD.
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M utant allele 
W ild  type allele
Figure 4 Pedigree of the family in which the PAX1 mutation is segregating. Presence of 
the mutation could be confirmed by A lul restriction digestion of the amplified PAXl paired 
domain fragment. Heterozygous carriers show a mutant allelic band in addition to the wild 
type band.
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Figure 5 Partial protein sequence of different human and murine P A X  genes showing that 
the glutamine (Q) residue at this position in the paired domain of the PAX1 gene is highly 
conserved. The patient carrying the PAX1 mutation has a histidine (H) residue at this 
position.
Based on data from the Splotch mouse and 
from the analysis of families and patients with 
Waardenburg syndrome^ the PAX3 gene is a 
likely candidate for neural tube defects. Link­
age analysis of multiple case families with the 
dinucleotide repeat marker25 immediately up­
stream of the PAX3 gene did not provide any 
indication for a major involvement of this 
gene,21 However, situations of negative linkage 
but positive allelic association have been 
reported for other genes and disorders, such as 
the TGFot gene in cleft lip and cleft palate.26 27 
With respect to NTD, no significant associ-
A
Turns
-------------
Alpha helices —  N
Beta sheets
PAX1 Wild type LPNAIRLRIVELAQLGIRPCDISRQLRVSHGCVSKILARYNETGSI
B
Turns
Alpha helices \
Beta sheets 
PAX1 Mutant
_  .  .  /  \
LPNAIRLRIVELAQLGIRPCDISRHLRVSHGCVSKILARYNETGSI
Figure 6 Results of the secondary protein structure prediction, of the wild type (A) and 
mutant (B) PAXJ peptidey respectively. Computer analysis, using the Chou-Fasman 
algorithm, shows the loss of a \5 sheet conformation at the position o f the mutation.
ation (p>0.1) was observed with any of the 
alleles of the dinucleotide polymorphism and 
similar results were obtained using patients 
and controls from the US population (not 
shown). Moreover no significant association 
was observed between N TD  and the newly 
detected polymorphisms described in this 
study, although suggestive results were ob­
tained witii the T  allele of a C/T silent 
polymorphism in exon 2 (p=0.06). The T  at 
the polymorphic site by itself does not 
necessarily have to be pathogenic to explain a 
possible association; however, one could imag­
ine that a difference in codon usage or 
pre-rnRNA processing might lead to a slight 
inequality in expression efficiency between 
both allelic forms of the PAX3 gene, In this 
respect, embryos with a T  allele would have a 
minor disadvantage during neurulation. How­
ever, at this point the evidence for association is 
not convincing and additional groups of 
patients need to be studied to determine 
whether the increased frequency of the T  allele 
in our patients has relevance for non- 
syndromal NTD.
In this study we have investigated whether 
particular members of the PAX gene family 
could play a role in the aetiology of human 
NTD. No indications for an involvement of 
PAX7 and PAX9 have been obtained so far. No 
significant association was detected between 
PAX3 and non-syndromal NTD. On the other 
hand, when considering the increased fre­
quency of NTD in WS1 families,19 PAX3 
mutations do seem to predispose to certain 
syndromic forms of NTD. Our present results 
argue for a role of the PAX1 gene in the aetiol­
ogy of N TD  as shown by the detection of a 
missense mutation in the paired domain. At 
the same time our data show that the detected 
mutation in PAX1 is not sufficient to cause the 
development of the disorder. Other factors, 
environmental or genetic or both, would have 
to exert a negative influence on the neurulation 
process to increase the risk further. From 
animal studies5 the gene for PDGFRa underly­
ing the Patch phenotype is a suspected 
candidate.
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